The Latest Breaking News from Johnson & Johnson (

About the new drug pricing negotiations

The first eligible drugs treat diabetes, blood clots, blood cancers, arthritis and heart disease

Salon · Sep 1, 2023

5 things consumers need to know about Medicare’s new drug-pricing negotiations, how they’ll affect you

This could help people whose Medicare drug plans require big copayments. But the main relief will come from part of the Inflation Reduction Act that caps drug spending by Medicare recipients at $2,000 a year starting in 2025.

Chicago Sun-Times · Aug 31, 2023

Cost of tuberculosis treatment halved in deal to permit generic versions

Johnson & Johnson’s year-long deal on life-saving drug bedaquiline is seen as critical move in campaign against disease

The Guardian - UK · Aug 31, 2023

Is Johnson & Johnson (JNJ) a Must-Buy Stability Stock?

Thanks to the company’s solid first-quarter performance and growing pharmaceutical demand, Johnson & Johnson’s (JNJ) long-term prospects look bright. However, could the company ensure stability for investors amid the current market volatility? Keep reading….

StockNews.com · Aug 1, 2023

Newest Fortune 500 member says large companies lose focus: 'You are little more remote from where the action is'

Kenvue, spun off from Johnson & Johnson in May, generated $15 billion in sales last year, enough to put it at rank 275 on 2022's Fortune 500 list.

Fortune · Jul 24, 2023

MSF calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug as main patent expires in India

MSF reiterated its call for Johnson & Johnson to publicly announce that it will not enforce any ‘secondary’ patents for bedaquiline in any country with a high burden of TB, as J&J’s 20-year primary patent on bedaquiline expired on July 18.

The Hindu · Jul 19, 2023

Cheaper TB drugs for millions after global deal on patent rights agreed

Johnson & Johnson allows generic bedaquiline in 44 countries – but concerns remain about ‘stopgap’ solution

The Guardian - UK · Jul 18, 2023

Johnson and Johnson shares licence for tuberculosis drug after novelist’s viral campaign

Disease kills millions each year even though it’s curable

The Independent UK · Jul 14, 2023

Is Tylenol linked to autism and ADHD?

The debate over how to interpret acetaminophen science has profound implications for individuals and the public

Salon · Jul 13, 2023

Seven murders by cyanide-laced Tylenol will never be solved. But the prime suspect’s death brings justice

After a joint FBI task force was unable to pin the 1982 Tylenol murders on prime suspect James Lewis, special agent Roy Lane was coaxed out of retirement to carry out a daring undercover mission. He tells Bevan Hurley Lewis’ death this week ‘puts the pursuit of justice to an…

The Independent UK · Jul 12, 2023